Mitochondrial dysfunction has been implicated in dozens of chronic diseases such as Alzheimer’s, macular degeneration, immune senescence, liver/kidney dysfunction, cardiovascular disease, frailty, mitochondrial mutation diseases, and more. How can we repair this dysfunction?

Researchers over the last decade have found that mitochondria can be transplanted into the body, where they are absorbed and used by cells. Mitrix is pioneering the application of this technique to adult age-related diseases and longevity treatments.

In the Mitrix process, healthy mitochondria are grown in bioreactors and transfused into the patient to bolster energy production and regenerate aged or dysfunctional tissues. The Mitrix team are recognized leaders in the field, working at research facilities around the world.


Team


Benedict Albensi Ph.D

Principal Investigator


Vinit Marhajan M.D. Ph.D.

Principal Investigator


George Wu M.D., Ph.D

Principal Investigator


Eric Boilard Ph.D

Principal Investigator


Martin Pelletier Ph.D

Principal Investigator



Advisors


Michael Snyder Ph.D

Scientific Advisor


Thomas Rando M.D. Ph.D

Scientific Advisor


Ronjon Nag, Ph.D

Scientific Advisor